Literature DB >> 21319263

Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapies.

Alejandro Vazquez-Martin, Silvia Cufí, Cristina Oliveras-Ferraros, Begoña Martin-Castillo, Sonia Del Barco, Eugeni López-Bonet, Javier A Menendez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21319263     DOI： 10.1002/gcc.20846

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


× No keyword cloud information.
  7 in total

Review 1.  Autophagy and endocrine resistance in breast cancer.

Authors:  Katherine L Cook; Ayesha N Shajahan; Robert Clarke
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

2.  Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.

Authors:  Alejandro Vazquez-Martin; Eugeni López-Bonetc; Sílvia Cufí; Cristina Oliveras-Ferraros; Sonia Del Barco; Begoña Martin-Castillo; Javier A Menendez
Journal:  Drug Resist Updat       Date:  2011-05-19       Impact factor: 18.500

3.  Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.

Authors:  Min Dong; Xiang-bo Wan; Zhong Yu Yuan; Li Wei; Xin Juan Fan; Tian-tian Wang; Yan Chun Lv; Xing Li; Zhan-hong Chen; Jie Chen; Qu Lin; Jing-yun Wen; Xiao-kun Ma; Quentin Liu; Xiang Yuan Wu
Journal:  Med Oncol       Date:  2013-02-14       Impact factor: 3.064

4.  Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.

Authors:  Elizabeth S Yeh; Melissa A Abt; Elizabeth G Hill
Journal:  Breast Cancer Res Treat       Date:  2014-12-17       Impact factor: 4.872

5.  Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.

Authors:  Sílvia Cufí; Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Bruna Corominas-Faja; Ander Urruticoechea; Begoña Martin-Castillo; Javier A Menendez
Journal:  Oncotarget       Date:  2012-12

6.  Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids.

Authors:  Cristina E Rodríguez; Sara I Reidel; Elisa D Bal de Kier Joffé; Maria A Jasnis; Gabriel L Fiszman
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

Review 7.  Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast Cancer.

Authors:  Joelle Zambrano; Elizabeth S Yeh
Journal:  Breast Cancer (Auckl)       Date:  2016-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.